New hope for tough cancers: experimental drug targets treatment resistance
NCT ID NCT03678883
First seen Apr 10, 2026 · Last updated Apr 16, 2026 · Updated 1 time
Summary
This study is testing a new drug called 9-ING-41, which is designed to block a protein that helps cancer cells survive and resist chemotherapy. It is for adults with advanced or metastatic cancers, including pancreatic, breast, and lung cancers, that have worsened despite standard treatments. The research aims to find safe doses and see if the drug, given alone or with common chemotherapies, can help control these difficult cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Health Network
Pittsburgh, Pennsylvania, 15212, United States
-
Arizona Oncology Associates
Tucson, Arizona, 85704, United States
-
Baptist Clinical Research Institute
Memphis, Tennessee, 38120, United States
-
CHRU Brest Hopital Morvan
Brest, Brittany Region, 29200, France
-
Capital Health Medical Center/ Hopewell
Pennington, New Jersey, 08534, United States
-
Center Hospitalier Regional Universitaire de Besancon - Site Jean Minjoz
Besançon, Bourgogne-Franche-Comté, 25030, France
-
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
-
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre
Greenfield Park, Quebec, G4V 2H1, Canada
-
Centro Hospitalar Universitario Sao Joao
Porto, 4200-319, Portugal
-
Christiana Care Health Services
Newark, Delaware, 19709, United States
-
Columbia University- Irving Medical Center
New York, New York, 10032, United States
-
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, 89128, United States
-
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
-
Des Moines Oncology Research Association
Des Moines, Iowa, 50309, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Florida Cancer Specialists - North
St. Petersburg, Florida, 33705, United States
-
Florida Cancer Specialists - South
Fort Myers, Florida, 33901, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
Fundacao Champalimaud
Lisbon, 1400-038, Portugal
-
Hopital Claude Huriez
Lille, Hauts-de-France, 59037, France
-
Hopital de la Timone
Marseille, 13005, France
-
Hospital Clinico U San Carlos (HSC)
Madrid, 28050, Spain
-
Hospital Da Luz
Lisbon, 1500-650, Portugal
-
INCLIVA University of Valencia
Valencia, 46010, Spain
-
Imelda VZW
Bonheiden, 2820, Belgium
-
Insitut de Cancerologie de l'Ouest
Saint-Herblain, Pays de la Loire Region, 44800, France
-
Institut Bergonie
Bordeaux, Nouvelle-Aquitaine, 33076, France
-
Institut Catala d'Oncologia
Barcelona, 8908, Spain
-
Institute de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, 54500, France
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Kansas University Cancer Center
Kansas City, Kansas, 66160, United States
-
MD Anderson Cancer Center at Cooper
Voorhees Township, New Jersey, 08043, United States
-
Mayo Clinic
Phoenix, Arizona, 85054, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
McGill University Health Centre
Montreal, Quebec, H4A 3J1, Canada
-
MetroMetro-Minnesota Community Oncology Research Consortium (MMCORC)
Minneapolis, Minnesota, 55416, United States
-
Miami Cancer Institute
Miami, Florida, 33176, United States
-
Morristown Medical Center
Morristown, New Jersey, 07960, United States
-
Netherlands Cancer Institute
Amsterdam, 1066 CX, Netherlands
-
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Prisma Health Cancer Institute
Greenville, South Carolina, 26905, United States
-
QE II Health Sciences Centre
Halifax, Nova Scotia, B3H 2Y9, Canada
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, Illinois, 60611, United States
-
START Madrid-HM CIOCC Hospital Universitario
Madrid, 28050, Spain
-
Sanford Research
Sioux Falls, South Dakota, 57105, United States
-
Sarah Cannon Research Institute- Tennessee Oncology-Nashville
Nashville, Tennessee, 37203, United States
-
Sibley Memorial Hospital
Washington D.C., District of Columbia, 20016, United States
-
St. Luke's University Health Network
Bethlehem, Pennsylvania, 18015, United States
-
Stony Brook University Hospital
Stony Brook, New York, 11794, United States
-
Texas Oncology- Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
-
The University of Arizona Cancer Center
Tucson, Arizona, 85719, United States
-
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94115, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
-
UW Carbone Cancer Center
Madison, Wisconsin, 53792, United States
-
UZ Gent
Ghent, 9000, Belgium
-
UZ Leuven Gasthuisberg
Leuven, 3000, Belgium
-
UZA- Antwerpen
Edegem, Antwerp, 2650, Belgium
-
University of California Irvine Health
Orange, California, 92868, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Utah Cancer Specialists
Salt Lake City, Utah, 84124, United States
-
Vall d'Hebron Institute of Oncology
Barcelona, 08035, Spain
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
West Cancer Center
Germantown, Tennessee, 38138, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
Conditions
Explore the condition pages connected to this study.